<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">Towards new recommendations to reduce the burden of alcohol-induced hypertension in the European Union</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName><forename type="first">Jürgen</forename><surname>Rehm</surname></persName>
							<idno type="ORCID">0000-0001-5665-0385</idno>
							<affiliation key="aff0">
								<orgName type="department">Institute of Clinical Psychology and Psychotherapy</orgName>
								<orgName type="institution">Technische Universität Dresden</orgName>
								<address>
									<settlement>Dresden</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="institution" key="instit1">Institute for Mental Health Policy Research</orgName>
								<orgName type="institution" key="instit2">Centre for Addiction and Mental Health</orgName>
								<address>
									<settlement>Toronto</settlement>
									<country key="CA">Canada</country>
								</address>
							</affiliation>
							<affiliation key="aff2">
								<orgName type="institution">Campbell Family Mental Health Research Institute</orgName>
							</affiliation>
							<affiliation key="aff3">
								<orgName type="institution">Centre for Addiction and Mental Health</orgName>
								<address>
									<settlement>Toronto</settlement>
									<country key="CA">Canada</country>
								</address>
							</affiliation>
							<affiliation key="aff4">
								<orgName type="department">Addiction Policy</orgName>
							</affiliation>
							<affiliation key="aff5">
								<orgName type="department">Dalla Lana School of Public Health</orgName>
								<orgName type="institution">University of Toronto</orgName>
								<address>
									<settlement>Toronto</settlement>
									<country key="CA">Canada</country>
								</address>
							</affiliation>
							<affiliation key="aff6">
								<orgName type="department" key="dep1">Institute of Medical Science</orgName>
								<orgName type="department" key="dep2">Faculty of Medicine</orgName>
								<orgName type="institution">University of Toronto</orgName>
							</affiliation>
							<affiliation key="aff7">
								<orgName type="department">Medical Sciences Building</orgName>
								<address>
									<settlement>Toronto</settlement>
									<country key="CA">Canada</country>
								</address>
							</affiliation>
							<affiliation key="aff8">
								<orgName type="department">Department of Psychiatry</orgName>
								<orgName type="institution">University of Toronto</orgName>
								<address>
									<settlement>Toronto</settlement>
									<country key="CA">Canada</country>
								</address>
							</affiliation>
							<affiliation key="aff9">
								<orgName type="department">Institute of Clinical Psychology and Psychotherapy</orgName>
								<orgName type="institution">Technische Universität Dresden</orgName>
								<address>
									<settlement>Dresden</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Peter</forename><surname>Anderson</surname></persName>
							<idno type="ORCID">0000-0001-5665-0385</idno>
							<affiliation key="aff10">
								<orgName type="department" key="dep1">Substance Use, Policy and Practice</orgName>
								<orgName type="department" key="dep2">Institute of Health and Society</orgName>
								<orgName type="institution">Newcastle University</orgName>
								<address>
									<settlement>Newcastle upon Tyne</settlement>
									<country key="GB">UK</country>
								</address>
							</affiliation>
							<affiliation key="aff11">
								<orgName type="department" key="dep1">Alcohol and Health</orgName>
								<orgName type="department" key="dep2">Faculty of Health, Medicine and Life Sciences</orgName>
								<orgName type="institution">Maastricht University</orgName>
								<address>
									<addrLine>Netherlands. 9 Primary Care Center La Eria</addrLine>
									<settlement>Maastricht, Oviedo</settlement>
									<country key="ES">Spain</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Jose</forename><surname>Angel</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Arbesu</forename><surname>Prieto</surname></persName>
							<affiliation key="aff12">
								<orgName type="department">Primary Care Spanish Society SEMERGEN</orgName>
								<address>
									<settlement>Madrid</settlement>
									<country key="ES">Spain</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Iain</forename><surname>Armstrong</surname></persName>
							<affiliation key="aff13">
								<orgName type="institution" key="instit1">Health and Wellbeing Directorate</orgName>
								<orgName type="institution" key="instit2">Public Health England</orgName>
								<address>
									<settlement>London</settlement>
									<country key="GB">UK</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Henri-Jean</forename><surname>Aubin</surname></persName>
							<affiliation key="aff14">
								<orgName type="institution" key="instit1">CESP</orgName>
								<orgName type="institution" key="instit2">University Paris-Sud</orgName>
							</affiliation>
							<affiliation key="aff15">
								<orgName type="institution" key="instit1">UVSQ</orgName>
								<orgName type="institution" key="instit2">INSERM</orgName>
								<orgName type="institution" key="instit3">Université Paris-Saclay</orgName>
								<orgName type="institution" key="instit4">APHP</orgName>
								<orgName type="institution" key="instit5">Hôpitaux Universitaires Paris-Sud</orgName>
								<address>
									<settlement>Villejuif</settlement>
									<country key="FR">France</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Michael</forename><surname>Bachmann</surname></persName>
							<affiliation key="aff16">
								<orgName type="institution">Copentown Healthcare Consultants</orgName>
								<address>
									<settlement>Cape Town</settlement>
									<country key="ZA">South Africa</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Nuria</forename><surname>Bastida Bastus</surname></persName>
							<affiliation key="aff17">
								<orgName type="institution" key="instit1">Primary Health Center</orgName>
								<orgName type="institution" key="instit2">Raval Nord</orgName>
								<address>
									<settlement>Barcelona</settlement>
									<country key="ES">Spain</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Carlos</forename><surname>Brotons</surname></persName>
							<affiliation key="aff18">
								<orgName type="institution" key="instit1">Sardenya Primary Health Care Center</orgName>
								<orgName type="institution" key="instit2">Biomedical Research Institute Sant Pau</orgName>
								<address>
									<settlement>Barcelona</settlement>
									<country key="ES">Spain</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Robyn</forename><surname>Burton</surname></persName>
							<affiliation key="aff13">
								<orgName type="institution" key="instit1">Health and Wellbeing Directorate</orgName>
								<orgName type="institution" key="instit2">Public Health England</orgName>
								<address>
									<settlement>London</settlement>
									<country key="GB">UK</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Manuel</forename><surname>Cardoso</surname></persName>
							<affiliation key="aff19">
								<orgName type="laboratory">General Directorate for Intervention on Addictive Behaviours and Dependencies (SICAD)</orgName>
								<address>
									<settlement>Lisbon</settlement>
									<country key="PT">Portugal</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Joan</forename><surname>Colom</surname></persName>
							<affiliation key="aff20">
								<orgName type="department" key="dep1">Program on Substance Abuse</orgName>
								<orgName type="department" key="dep2">Department of Health</orgName>
								<orgName type="institution">Public Health Agency of Catalonia</orgName>
							</affiliation>
							<affiliation key="aff21">
								<orgName type="department">Government of Catalonia</orgName>
								<address>
									<settlement>Barcelona</settlement>
									<country key="ES">Spain</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Daniel</forename><surname>Duprez</surname></persName>
							<affiliation key="aff22">
								<orgName type="department" key="dep1">Cardiovascular Division</orgName>
								<orgName type="department" key="dep2">School of Medicine</orgName>
								<orgName type="institution">University of Minnesota</orgName>
								<address>
									<settlement>Minneapolis</settlement>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Gerrit</forename><surname>Gmel</surname></persName>
							<affiliation key="aff1">
								<orgName type="institution" key="instit1">Institute for Mental Health Policy Research</orgName>
								<orgName type="institution" key="instit2">Centre for Addiction and Mental Health</orgName>
								<address>
									<settlement>Toronto</settlement>
									<country key="CA">Canada</country>
								</address>
							</affiliation>
							<affiliation key="aff23">
								<orgName type="laboratory">Implant Systems Group</orgName>
								<orgName type="institution">National ICT Australia</orgName>
								<address>
									<settlement>Eveleigh</settlement>
									<country key="AU">Australia</country>
								</address>
							</affiliation>
							<affiliation key="aff24">
								<orgName type="department">Faculty of Engineering</orgName>
								<orgName type="institution">University of New South Wales</orgName>
								<address>
									<settlement>Sydney</settlement>
									<country key="AU">Australia</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Antoni</forename><surname>Gual</surname></persName>
							<affiliation key="aff25">
								<orgName type="department">Psychiatry Department</orgName>
								<orgName type="institution" key="instit1">Addictions Unit</orgName>
								<orgName type="institution" key="instit2">Neurosciences Institute, Hospital Clinic</orgName>
								<orgName type="institution" key="instit3">IDIBAPS</orgName>
								<address>
									<settlement>Barcelona</settlement>
									<country key="ES">Spain</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Ludwig</forename><surname>Kraus</surname></persName>
							<affiliation key="aff26">
								<orgName type="department">IFT Institut für Therapieforschung</orgName>
								<address>
									<settlement>Munich</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff27">
								<orgName type="department">Centre for Social Research on Alcohol and Drugs (SoRAD)</orgName>
								<orgName type="institution">Stockholm University</orgName>
								<address>
									<settlement>Stockholm</settlement>
									<country key="SE">Sweden</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Reinhold</forename><surname>Kreutz</surname></persName>
							<affiliation key="aff28">
								<orgName type="department">Institute of Clinical Pharmacology and Toxicology</orgName>
								<orgName type="institution">Charité -Universitätsmedizin Berlin</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Helena</forename><surname>Liira</surname></persName>
							<affiliation key="aff29">
								<orgName type="department">School of Primary, Aboriginal and Rural Health Care</orgName>
								<orgName type="institution" key="instit1">General Practice</orgName>
								<orgName type="institution" key="instit2">University of Western Australia</orgName>
								<address>
									<settlement>Perth</settlement>
									<country key="AU">Australia</country>
								</address>
							</affiliation>
							<affiliation key="aff30">
								<orgName type="department">Department of General Practice</orgName>
								<orgName type="institution" key="instit1">University of Helsinki</orgName>
								<orgName type="institution" key="instit2">Helsinki University Central Hospital</orgName>
								<orgName type="institution" key="instit3">Unit of Primary Health Care</orgName>
								<address>
									<settlement>Helsinki</settlement>
									<country key="FI">Finland</country>
								</address>
							</affiliation>
						</author>
						<author role="corresp">
							<persName><forename type="first">Jakob</forename><surname>Manthey</surname></persName>
							<email>jakob.manthey@tu-dresden.de</email>
							<idno type="ORCID">0000-0003-1231-3760</idno>
							<affiliation key="aff0">
								<orgName type="department">Institute of Clinical Psychology and Psychotherapy</orgName>
								<orgName type="institution">Technische Universität Dresden</orgName>
								<address>
									<settlement>Dresden</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff9">
								<orgName type="department">Institute of Clinical Psychology and Psychotherapy</orgName>
								<orgName type="institution">Technische Universität Dresden</orgName>
								<address>
									<settlement>Dresden</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Lars</forename><surname>Møller</surname></persName>
							<idno type="ORCID">0000-0003-1231-3760</idno>
							<affiliation key="aff31">
								<orgName type="institution" key="instit1">Division of Noncommunicable Diseases through the Life Course</orgName>
								<orgName type="institution" key="instit2">WHO Regional Office for Europe</orgName>
								<address>
									<settlement>Copenhagen</settlement>
									<country key="DK">Denmark</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Ľubomír</forename><surname>Okruhlica</surname></persName>
							<affiliation key="aff32">
								<orgName type="institution">Centrum pre Liecbu Drogovych Zavislosti</orgName>
								<address>
									<settlement>Bratislava</settlement>
									<country key="SK">Slovakia</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Michael</forename><surname>Roerecke</surname></persName>
							<affiliation key="aff1">
								<orgName type="institution" key="instit1">Institute for Mental Health Policy Research</orgName>
								<orgName type="institution" key="instit2">Centre for Addiction and Mental Health</orgName>
								<address>
									<settlement>Toronto</settlement>
									<country key="CA">Canada</country>
								</address>
							</affiliation>
							<affiliation key="aff2">
								<orgName type="institution">Campbell Family Mental Health Research Institute</orgName>
							</affiliation>
							<affiliation key="aff3">
								<orgName type="institution">Centre for Addiction and Mental Health</orgName>
								<address>
									<settlement>Toronto</settlement>
									<country key="CA">Canada</country>
								</address>
							</affiliation>
							<affiliation key="aff4">
								<orgName type="department">Addiction Policy</orgName>
							</affiliation>
							<affiliation key="aff5">
								<orgName type="department">Dalla Lana School of Public Health</orgName>
								<orgName type="institution">University of Toronto</orgName>
								<address>
									<settlement>Toronto</settlement>
									<country key="CA">Canada</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Emanuele</forename><surname>Scafato</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Bernd</forename><surname>Schulte</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Lidia</forename><surname>Segura-Garcia</surname></persName>
							<affiliation key="aff20">
								<orgName type="department" key="dep1">Program on Substance Abuse</orgName>
								<orgName type="department" key="dep2">Department of Health</orgName>
								<orgName type="institution">Public Health Agency of Catalonia</orgName>
							</affiliation>
							<affiliation key="aff21">
								<orgName type="department">Government of Catalonia</orgName>
								<address>
									<settlement>Barcelona</settlement>
									<country key="ES">Spain</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Kevin</forename><forename type="middle">David</forename><surname>Shield</surname></persName>
							<affiliation key="aff1">
								<orgName type="institution" key="instit1">Institute for Mental Health Policy Research</orgName>
								<orgName type="institution" key="instit2">Centre for Addiction and Mental Health</orgName>
								<address>
									<settlement>Toronto</settlement>
									<country key="CA">Canada</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Cristina</forename><surname>Sierra</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Konstantin</forename><surname>Vyshinskiy</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Marcin</forename><surname>Wojnar</surname></persName>
						</author>
						<author>
							<persName><forename type="first">José</forename><surname>Zarco</surname></persName>
						</author>
						<title level="a" type="main">Towards new recommendations to reduce the burden of alcohol-induced hypertension in the European Union</title>
					</analytic>
					<monogr>
						<imprint>
							<date/>
						</imprint>
					</monogr>
					<idno type="MD5">231C827FE462D176A9C087413D7307A6</idno>
					<idno type="DOI">10.1186/s12916-017-0934-1</idno>
					<note type="submission">Received: 24 October 2016 Accepted: 22 August 2017</note>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.7.2-SNAPSHOT" ident="GROBID" when="2022-05-18T11:41+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<textClass>
				<keywords>
					<term>Hypertension</term>
					<term>Blood pressure</term>
					<term>Alcohol use</term>
					<term>Primary healthcare</term>
					<term>Europe</term>
					<term>Screening</term>
					<term>Management</term>
					<term>Recommendations</term>
				</keywords>
			</textClass>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0"><p><s>Background: Hazardous and harmful alcohol use and high blood pressure are central risk factors related to premature non-communicable disease (NCD) mortality worldwide.</s><s>A reduction in the prevalence of both risk factors has been suggested as a route to reach the global NCD targets.</s><s>This study aims to highlight that screening and interventions for hypertension and hazardous and harmful alcohol use in primary healthcare can contribute substantially to achieving the NCD targets.</s><s>Methods: A consensus conference based on systematic reviews, meta-analyses, clinical guidelines, experimental studies, and statistical modelling which had been presented and discussed in five preparatory meetings, was undertaken.</s><s>Specifically, we modelled changes in blood pressure distributions and potential lives saved for the five largest European countries if screening and appropriate intervention rates in primary healthcare settings were increased.</s><s>Recommendations to handle alcohol-induced hypertension in primary healthcare settings were derived at the conference, and their degree of evidence was graded.</s><s>Results: Screening and appropriate interventions for hazardous alcohol use and use disorders could lower blood pressure levels, but there is a lack in implementing these measures in European primary healthcare.</s><s>Recommendations included (1) an increase in screening for hypertension (evidence grade: high), (2) an increase in screening and brief advice on hazardous and harmful drinking for people with newly detected hypertension by physicians, nurses, and other healthcare professionals (evidence grade: high), (3) the conduct of clinical management of less severe alcohol use disorders for incident people with hypertension in primary healthcare (evidence grade: moderate), and (4) screening for alcohol use in hypertension that is not well controlled (evidence grade: moderate).</s><s>The first three measures were estimated to result in a decreased hypertension prevalence and hundreds of saved lives annually in the examined countries.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Conclusions:</head><p><s>The implementation of the outlined recommendations could contribute to reducing the burden associated with hypertension and hazardous and harmful alcohol use and thus to achievement of the NCD targets.</s><s>Implementation should be conducted in controlled settings with evaluation, including, but not limited to, economic evaluation.</s></p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Background</head><p><s>Alcohol and hypertension as risk factors for noncommunicable diseases (NCDs)</s></p><p><s>In May 2013, the World Health Organization (WHO) adopted a Global Action Plan for the Prevention and Control of Non-communicable Diseases for the period 2013-2020.</s><s>The main target <ref type="bibr" target="#b0">[1]</ref> comprises a 25% reduction in the risk of premature mortality from cardiovascular diseases, cancer, diabetes, or chronic respiratory diseases.</s><s>To achieve this overall target, a number of individual targets for risk factors have been established, including, but not limited to, at least a 10% reduction in the harmful use of alcohol and a 25% reduction in the prevalence, or limitation of the increase in the prevalence, of raised blood pressure (BP), according to national circumstances.</s><s>For countries of the European Union, given the consistently high rates of raised BP over the past decades (e.g., <ref type="bibr" target="#b1">[2]</ref>), the 25% reduction of prevalence seems most appropriate <ref type="bibr" target="#b2">[3]</ref>.</s></p><p><s>It has been estimated that, if the main targets for risk factors were to be achieved, the overall goal for reduction of premature mortality would be practically reached at the global level <ref type="bibr" target="#b3">[4]</ref>, and would be exceeded in the European region <ref type="bibr" target="#b4">[5]</ref>.</s><s>The measures proposed to reach the NCD goals are centered around the so-called "best buys" of the WHO, interventions that are not only highly cost-effective but also feasible and appropriate to implement within the respective health systems <ref type="bibr" target="#b5">[6]</ref>.</s><s>Best buys for alcohol comprise taxation increases, restrictions on availability, and a ban on marketing for alcohol use.</s><s>For hypertension, best buys were more scarce, as only a reduction of salt intake was listed (Appendix 3 of reference <ref type="bibr" target="#b0">[1]</ref>) <ref type="bibr" target="#b5">[6]</ref><ref type="bibr" target="#b6">[7]</ref><ref type="bibr" target="#b7">[8]</ref>.</s><s>Herein, we will show, using data from five European countries, that screening and interventions for both hazardous and harmful use of alcohol (including alcohol use disorders (AUDs)) and for hypertension in primary healthcare can also lead to public health-relevant reductions of NCDs in Europe, albeit at higher costs than best buys (see point on economic considerations below), as these are individual-level interventions.</s><s>In addition, this paper will list recommendations from a consensus conference on what should be performed to achieve these reductions.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Methods</head><p><s>Herein, the various stages in preparation for and the activities performed at the consensus conference on "Screening and intervention for harmful alcohol use as a tool to improve the management of hypertension in primary care" will be outlined.</s><s>The conference took place in Barcelona on 12th November, 2015, by invitation of the Public Health Agency of Catalonia (see Additional file 1: Appendix 1 for the agenda).</s><s>Catalonia is one of the few jurisdictions in Europe which has integrated yearly screening for alcohol consumption into its primary healthcare plan.</s><s>The Public Health Agency prepared the conference <ref type="bibr" target="#b8">[9]</ref>.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Input into the conference</head><p><s>In preparation for the conference, a number of national meetings on its topic were held in Belgium <ref type="bibr" target="#b9">[10]</ref>, Finland <ref type="bibr" target="#b10">[11]</ref>, Germany <ref type="bibr" target="#b13">[12]</ref>, Spain <ref type="bibr" target="#b14">[13]</ref>, and the UK <ref type="bibr" target="#b15">[14]</ref>, where presentations of systematic reviews and meta-analyses on causality and the relationship between drinking and BP (see below for a summary) and of systematic reviews on the effects of alcohol intervention on BP (see below for a summary) were held.</s><s>Further, modelling of the potential impact of primary care interventions on alcohol (technical details on the modelling are listed in Appendix 2, following the stipulations of the GATHER statement <ref type="bibr" target="#b16">[15]</ref>) was performed and the results from a survey among primary care physicians on practices concerning alcohol screening and interventions in the management of hypertension <ref type="bibr" target="#b17">[16]</ref> were presented.</s><s>Finally, draft recommendations, prepared on the basis of the abovementioned national meetings, were put forward.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Steps towards consensus</head><p><s>Each draft recommendation was discussed extensively with a preliminary wording.</s><s>It was agreed that the preliminary wordings would be circulated again to all participants to achieve a final consensus, together with new evidence as available.</s><s>The second consultation period took place between 20th September and 20th October, 2016.</s><s>As part of the revision process for the journal article, new evidence was incorporated and there was a third consultation between February 16th and March 1st, 2017.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Grading the recommendations</head><p><s>We based our recommendations on the GRADE (Grading of Recommendations Assessment, Development and Evaluation) approach, which rates the quality of evidence for a particular outcome across studies and does not rate the quality of individual studies <ref type="bibr" target="#b18">[17,</ref><ref type="bibr" target="#b19">18]</ref>.</s><s>For some recommendations, we took the evidence grades from the respective review of UK National Institute for Heath and Care Excellence (NICE), which used the same system to grade the quality of evidence as high, moderate, low, or very low <ref type="bibr" target="#b20">[19]</ref>.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Results and Discussion</head><p><s>The evidence for alcohol interventions to reduce BP Several systematic reviews and meta-analyses have shown that alcohol consumption and hypertension are linked in a dose-dependent fashion <ref type="bibr" target="#b21">[20]</ref><ref type="bibr" target="#b22">[21]</ref><ref type="bibr" target="#b23">[22]</ref><ref type="bibr" target="#b24">[23]</ref>, although there may be a threshold level for alcohol consumption below which there are no effects, especially for women <ref type="bibr" target="#b25">[24,</ref><ref type="bibr" target="#b26">25]</ref> (for indirect evidence see <ref type="bibr" target="#b27">[26]</ref>).</s><s>As indicated by the potential threshold, the dose-response relationship is not linear over the full range of alcohol consumption, but for both sexes there is a monotonic dose-response relationship for higher levels of consumption <ref type="bibr" target="#b21">[20,</ref><ref type="bibr" target="#b23">22,</ref><ref type="bibr" target="#b25">24]</ref>, and thus hazardous/ harmful drinking and AUDs are closely associated with elevated BP and/or hypertension <ref type="bibr" target="#b24">[23,</ref><ref type="bibr" target="#b28">27,</ref><ref type="bibr" target="#b29">28]</ref>.</s><s>The above described association between hazardous/harmful alcohol consumption and hypertension has been judged as causal <ref type="bibr" target="#b30">[29]</ref><ref type="bibr" target="#b31">[30]</ref><ref type="bibr" target="#b32">[31]</ref>, which means that a logical intervention to reduce BP is to reduce alcohol consumption.</s></p><p><s>Indeed, several studies support the efficacy and effectiveness of interventions to decrease alcohol consumption in reducing BP levels, with a clinically meaningful decline in BP occurring within a few weeks after reductions in alcohol intake among hypertensive patients <ref type="bibr" target="#b31">[30,</ref><ref type="bibr" target="#b33">32,</ref><ref type="bibr" target="#b34">33]</ref>.</s><s>The most comprehensive systematic review and meta-analyses on the effect of alcohol consumption on BP in trials lasting at least 7 days (median duration: 4 weeks) found that, above a baseline drinking level of two drinks per day (drink size was assumed to be 12 g pure alcohol), reduction in alcohol intake was associated with BP reduction <ref type="bibr" target="#b35">[34]</ref>.</s><s>The higher the alcohol consumption at baseline, the greater the reduction in alcohol consumption and in BP levels.</s><s>The effect could also be shown for people with hypertension <ref type="bibr" target="#b35">[34]</ref>.</s><s>The evidence supporting this intervention is of the highest possible grade <ref type="bibr" target="#b36">[35]</ref>, as it is based on a systematic review and meta-analyses of randomized controlled trials of interventions to reduce BP in both normotensives and hypertensives, with adequate control groups (for the importance of control groups specifically in the area of interventions for lowering BP see the paper by Patel et al. <ref type="bibr" target="#b37">[36]</ref>).</s></p><p><s>The available evidence has led to standard formulations in European and Canadian guidelines for the management of hypertension in the past decades to address lifestyle factors, including alcohol <ref type="bibr" target="#b38">[37,</ref><ref type="bibr" target="#b40">38]</ref>.</s><s>In fact, most guidelines, including those from the NICE, stipulate that all patients undergoing assessment or treatment for hypertension should receive initial and periodic lifestyle advice, which includes ascertaining their alcohol consumption and encouraging a reduced intake if they drink hazardously <ref type="bibr" target="#b41">[39]</ref>.</s></p><p><s>The situation in the US is slightly different.</s><s>Although American Society of Hypertension Community Guidelines briefly mention the contribution of alcohol to raised BP <ref type="bibr" target="#b42">[40]</ref>, the association between alcohol consumption and raised BP is not even mentioned in the main national hypertension guidelines <ref type="bibr" target="#b43">[41]</ref> or in the American College of Cardiology/American Heart Association Guidelines regarding lifestyle management to reduce cardiovascular risk <ref type="bibr" target="#b44">[42]</ref>.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Interventions to reduce alcohol consumption</head><p><s>In the primary care settings, there is significant overlap of hazardous drinking/AUDs (for background see <ref type="bibr" target="#b45">[43]</ref>) and hypertension.</s><s>European evidence suggests that 20.6% of hypertensive men aged 40-65 years have an AUD and 16.7% have alcohol dependence.</s><s>For hypertensive women aged 40-65 years, it is estimated that 7.2% have an AUD and 5.8% have alcohol dependence <ref type="bibr" target="#b13">[12]</ref>.</s><s>Adding these people to those who do not qualify for an AUD diagnosis but drink above 60 g or 40 g of pure alcohol per day (for men and women, respectively), resulted in 30.9% or 20.0% of men and women aged 40-65 years, respectively, qualifying for alcohol interventions with hypertension.</s><s>Compared to those without any AUD, patients with an AUD are estimated to have a 1.5to 5-fold increased risk of hypertension, with the highest risks for hypertension involving higher levels of alcohol consumption <ref type="bibr" target="#b46">[44]</ref><ref type="bibr" target="#b47">[45]</ref><ref type="bibr" target="#b48">[46]</ref>.</s><s>In the above-cited study of more than 13,000 patients in primary healthcare <ref type="bibr" target="#b29">[28,</ref><ref type="bibr" target="#b49">47]</ref>, the age-adjusted odds ratio (OR) for hypertension in the age group 40-64 years was 1.59 among those diagnosed with AUD by the treating general practitioner (95% CI 1.35-1.88,</s><s>P &lt; 0.001; own calculationssee Additional file 2: Appendix 2) <ref type="bibr" target="#b49">[47]</ref><ref type="bibr" target="#b50">[48]</ref><ref type="bibr" target="#b51">[49]</ref>.</s></p><p><s>Looking at the odds from hypertension in the cited study, the age-adjusted OR for an AUD was, of course, similar (OR 1.60, 95% CI 1.35-1.88,</s><s>P &lt; 0.001) because of the symmetry property of OR, and the odds of qualifying for an intervention among people with hypertension was 1.35 (95% CI 1.12-1.58,</s><s>P &lt; 0.001; own calculations; for a description of the study see <ref type="bibr" target="#b49">[47]</ref><ref type="bibr" target="#b50">[48]</ref><ref type="bibr" target="#b51">[49]</ref>).</s></p><p><s>Since a reduction in alcohol consumption leads to a decline in BP levels <ref type="bibr" target="#b33">[32,</ref><ref type="bibr" target="#b35">34]</ref>, the question becomes whether effective interventions to reduce alcohol consumption are available in primary healthcare.</s><s>There is ample evidence, based on randomized controlled trials in many countries, that screening and brief advice are effective in reducing alcohol consumption in hazardous and harmful drinkers <ref type="bibr" target="#b52">[50]</ref>, and that effective psychotherapies and pharmacotherapy plus psychosocial interventions are effective in reducing consumption levels in dependent drinkers <ref type="bibr" target="#b53">[51]</ref><ref type="bibr" target="#b54">[52]</ref><ref type="bibr" target="#b55">[53]</ref><ref type="bibr" target="#b56">[54]</ref><ref type="bibr" target="#b57">[55]</ref>.</s><s>Despite this evidence, and its inclusion in some guidelines <ref type="bibr" target="#b38">[37,</ref><ref type="bibr" target="#b41">39]</ref>, interventions to reduce alcohol consumption do not play a major role in the management of hypertension at the primary healthcare level in many European countries <ref type="bibr" target="#b17">[16,</ref><ref type="bibr" target="#b58">56]</ref>.</s><s>One example that illustrates the paucity of activity in primary healthcare is the recent five-country Optimizing Delivery of Health Care Interventions study that recruited 120 primary healthcare units from Catalonia, England, Netherlands, Poland, and Sweden <ref type="bibr" target="#b59">[57]</ref>.</s><s>During the 4week baseline measurement period, in only 1202 out of 179,954 adult consultations (0.67%) were patients screened for and advised about their hazardous drinking.</s></p><p><s>Studies have identified a number of potential barriers to the adoption of screening and brief advice in primary healthcare, including the lack of resources, training and support from management, as well as workload <ref type="bibr" target="#b60">[58,</ref><ref type="bibr" target="#b61">59]</ref>.</s><s>Given this situation, experts in several countries have started to take steps towards better integration of alcohol interventions in primary healthcare <ref type="bibr" target="#b9">[10]</ref><ref type="bibr" target="#b10">[11]</ref><ref type="bibr" target="#b13">[12]</ref><ref type="bibr" target="#b14">[13]</ref><ref type="bibr" target="#b15">[14]</ref>.</s><s>Despite obvious differences between healthcare systems, there are clear commonalities in the recommendations made by the different sets of national experts.</s><s>These recommendations focus on providing incentives for screening and treatment, better education for primary healthcare providers regarding the link between alcohol and hypertension, and the inclusion of simple alcohol tools in electronic patient records, such that the management of alcohol use becomes standard practice for all patients with hypertension.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>The potential in Europeexamples from five countries</head><p><s>While control and management of hypertension is a key element of any European guideline for primary healthcare, most general population surveys show that a large minority of women and the majority of men with hypertension aged 40 to 64 either do not know about their health condition or are not adequately controlled (i.e., they show BP values ≥ 140/90 mm Hg; see Table <ref type="table" target="#tab_0">1</ref></s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>for details).</head><p><s>The following models the joint effects of two interventions (see Additional file 2: Appendix 2).</s><s>First, it is assumed that 50% of the people aged 40-64 years with uncontrolled hypertension (i.e., BP ≥ 140/90 mm Hg <ref type="bibr" target="#b38">[37,</ref><ref type="bibr" target="#b62">60,</ref><ref type="bibr" target="#b63">61]</ref>) receive an intervention (in part but not limited to pharmacotherapy <ref type="bibr" target="#b38">[37]</ref>), which lowers their BP level to that of people with controlled hypertension.</s><s>Secondly, it is assumed that, among those with uncontrolled hypertension who are receiving hypertension interventions, 50% of those eligible will also receive either brief advice or a brief intervention for hazardous or harmful alcohol use, or treatment for alcohol dependence.</s><s>The results are summarized in Table <ref type="table" target="#tab_1">2</ref>.</s></p><p><s>In each of the countries, the proposed intervention would have a sizeable effect on improving BP levels among 40-to 65-year-old hypertensives and would markedly increase the proportion of people below the threshold 140/90 mm Hg in the general population (for men, between 1.5% and 5.3%; for women, between 1.0% and 2.0%).</s><s>Both effects are more pronounced in men, which is not surprising, as men have worse control of BP in all countries and, relatedly, they have worse alcohol consumption habits <ref type="bibr" target="#b0">[1]</ref> (Table <ref type="table" target="#tab_1">2</ref>).</s></p><p><s>The next set of calculations measures the impact of the proposed interventions on mortality and burden of disease as measured in disability-adjusted live years (DALYs) in the same age group within 1 year, using the methodology of comparative risk assessment <ref type="bibr" target="#b64">[62,</ref><ref type="bibr" target="#b65">63]</ref> (see Additional file 2: Appendix 2).</s><s>This limitation for 1 year is consistent with knowledge that brief intervention effects will show some attrition over time <ref type="bibr" target="#b66">[64]</ref>.</s></p><p><s>The potential effect of the interventions on reducing mortality would be sizeable.</s><s>In each of the five countries examined, the reductions of BP and the effects of reduced alcohol would lead to hundreds of deaths avoided within 1 year (Table <ref type="table" target="#tab_2">3</ref>); for instance, in Germany alone, a reduction of 1536 cardiovascular disease deaths, 138 gastrointestinal deaths, and 20 injury deaths.</s><s>In terms of burden of disease, for Germany, about 86,000 years of life lost due to cardiovascular premature mortality or due to disability in this age group could be avoided, plus another 5500 due to gastrointestinal disease and 3000 due to injury.</s></p><p><s>This does not even include the effect of reduced alcohol use on other disease categories such as AUDs or cancer.</s><s>For the latter disease category, the effects would only be seen after decades due to the long time lag <ref type="bibr" target="#b67">[65]</ref>.</s><s>For the other disease categories, lag times are short <ref type="bibr" target="#b68">[66]</ref>, and the vast majority of deaths will be covered, including liver cirrhosis deaths, where interventions have shown immediate effects <ref type="bibr" target="#b69">[67]</ref>.</s></p><p><s>Recommendations 1) Increase screening for hypertension in primary healthcare.</s></p><p><s>Evidence grade: High.</s><s>Despite control of hypertension being an integral part of primary healthcare in most European countries, a measurable proportion of the patients with undetected hypertension is evident in all countries, usually among the younger age groups (see Table <ref type="table" target="#tab_0">1</ref> for details for the five countries modelled).</s><s>As a result, many countries make specific recommendations for    <ref type="bibr" target="#b70">[68]</ref><ref type="bibr" target="#b71">[69]</ref><ref type="bibr" target="#b72">[70]</ref> or large trials <ref type="bibr" target="#b73">[71]</ref>).</s><s>The evidence for these screening efforts was graded as the highest possible quality, and current explorations are mainly concerned with best techniques for assessing BP <ref type="bibr" target="#b70">[68,</ref><ref type="bibr" target="#b74">72]</ref>.</s><s>2) Increase screening and brief advice on hazardous and harmful drinking for people with newly detected hypertension from physicians, nurses, and other healthcare professionals in primary healthcare.</s></p><p><s>Evidence grade: High.</s><s>Even though this recommendation has not been implemented into clinical practice in most countries, the evidence grade from controlled clinical studies has been evaluated as consistently high (see <ref type="bibr" target="#b52">[50,</ref><ref type="bibr" target="#b66">64,</ref><ref type="bibr" target="#b75">73]</ref> for effectiveness of brief advice for reducing drinking; see <ref type="bibr" target="#b33">[32,</ref><ref type="bibr" target="#b35">34]</ref> for meta-analyses of alcohol interventions on BP, including on BP levels of people with hypertension).</s><s>3) Treatment for less severe alcohol use disorders in people with incident hypertension should be conducted in primary healthcare, including but not limited to pharmacologically assisted treatment.</s></p><p><s>Evidence grade: Moderate.</s><s>While there are some recommendations for treatment of less severe AUDs in primary healthcare <ref type="bibr" target="#b76">[74]</ref><ref type="bibr" target="#b77">[75]</ref><ref type="bibr" target="#b78">[76]</ref> and randomized controlled trials on specific elements of this strategy (e.g., effectiveness of medicationassisted treatment <ref type="bibr" target="#b79">[77,</ref><ref type="bibr" target="#b80">78]</ref>), the strategy has not been systematically tested in randomized controlled clinical trials.</s><s>Additionally, to date, it has not been tested specifically for people with hypertension in primary healthcare, even though there is evidence from randomized controlled trials that treatment for AUDs can lower BP <ref type="bibr" target="#b34">[33,</ref><ref type="bibr" target="#b81">[79]</ref><ref type="bibr" target="#b82">[80]</ref><ref type="bibr" target="#b83">[81]</ref>.</s><s>This is to be expected, as AUDs are strongly associated with hazardous or harmful drinking levels <ref type="bibr" target="#b45">[43,</ref><ref type="bibr" target="#b84">82]</ref>, and abstinence or reduction of drinking is the main outcome variable in most of these trials <ref type="bibr" target="#b85">[83]</ref>.</s><s>4) Screen for alcohol use in hypertension that is not well controlled.</s></p><p><s>Evidence grade: Moderate.</s><s>Current guidelines for the management for treatment-resistant hypertension, comprising approximately 8-12% of patients with uncontrolled BP <ref type="bibr" target="#b86">[84]</ref>, emphasize screening of alcohol use and reduction of hazardous or harmful drinking levels <ref type="bibr" target="#b87">[85,</ref><ref type="bibr" target="#b88">86]</ref>.</s><s>However, there are no randomized clinical trials underlying this recommendation; it is supported mainly by biological plausibility and, in a recent assessment <ref type="bibr" target="#b88">[86]</ref>, the relevant committee of the French Society for Hypertension gave it a moderate evidence grade.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Economic considerations</head><p><s>Thus far, we have only considered estimated effects of implementing both interventions, indicating public health-relevant effects on BP and premature mortality (as all calculations were restricted to people aged 40-65 years).</s><s>Others have shown effects on wider outcomes as well (see <ref type="bibr" target="#b35">[34]</ref> for effects on BP-attributable hospitalizations; Organisation for Economic Co-operation and Development <ref type="bibr" target="#b89">[87]</ref> for estimating and comparing effects on alcohol interventions on disease burden).</s><s>For any change in healthcare systems, information about costs are also necessary, as effective interventions may not be taken up if they are not cost-effective.</s><s>A recent systematic review showed that brief interventions in primary healthcare have also been shown to be cost-effective <ref type="bibr" target="#b90">[88]</ref>.</s><s>In addition, Angus et al. <ref type="bibr" target="#b91">[89]</ref> estimated, by modelling potential effects of implementing screening and brief interventions for hazardous or harmful drinking, that these programs were likely to be cost-effective in 24 out of 28 European Union countries and cost-saving in 50% of these.</s><s>They concluded that implementing national alcohol intervention programs in primary healthcare would be a cost-effective means to reduce health burden.</s><s>However, it should be noted that the work of Angus et al. <ref type="bibr" target="#b91">[89]</ref> was not limited to the consequences mediated by BP, but included all health consequences.</s><s>Given these numbers, and bearing in mind that there is only one best buy for hypertension (Appendix 3 of <ref type="bibr" target="#b0">[1]</ref>) and, further, that the three best buys for alcohol have been rarely considered by decision-makers given the strong impact of economic operators and the fear that taxation increases and availability restrictions would prove unpopular with many voters <ref type="bibr" target="#b92">[90]</ref>, implementing alcohol interventions for people with newly detected hypertension seems an attractive and feasible option to improve public health at relatively low, or for some jurisdictions, no overall costs.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Potential for implementation and conclusions</head><p><s>All of the four recommendations have been chosen as measurable, achievable, and realistic for implementation in primary healthcare.</s><s>Obviously, as with all recommendations, implementations should be carefully evaluated.</s><s>While we have laid out the economic arguments for implementing the recommendations, these are currently based on assumptions and different modelling approaches.</s><s>More controlled approaches with randomization should be used to study the effects of the recommendations.</s><s>Moreover, evaluations, including but not limited to economic evaluations <ref type="bibr" target="#b93">[91]</ref>, are necessary to create sustainable policies, which could be defended in times of scarce resources.</s></p></div><figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_0"><head>Table 1</head><label>1</label><figDesc><div><p><s>Proportion with hypertension with or without control in large population surveys among 40-64 year olds</s></p></div></figDesc><table><row><cell></cell><cell cols="2">Proportion of people with hypertension a</cell><cell cols="2">Proportion recognized or in treatment (with or without adequate control) b</cell><cell>Fieldwork of</cell></row><row><cell></cell><cell>Women</cell><cell>Men</cell><cell>Women</cell><cell>Men</cell><cell>main study</cell></row><row><cell>France</cell><cell>30.4%</cell><cell>46.2%</cell><cell>64.0%</cell><cell>36.1%</cell><cell>2006-2007</cell></row><row><cell cols="2">Germany 29.6%</cell><cell>36.5%</cell><cell>56.0%</cell><cell>40.1%</cell><cell>2008-2011</cell></row><row><cell>Italy</cell><cell>33.2%</cell><cell>42.1%</cell><cell>52.0%</cell><cell>40.4%</cell><cell>2008-2012</cell></row><row><cell>Spain</cell><cell>30.0%</cell><cell>42.0%</cell><cell>62.0%</cell><cell>48.1%</cell><cell>2008-2010</cell></row><row><cell>UK</cell><cell>22.6%</cell><cell>27.2%</cell><cell>31.2%</cell><cell>23.9%</cell><cell>2006</cell></row></table><note><p><s>For definitions and sources, see Additional file 2: Appendix 2 a Hypertension was defined by a blood pressure ≥ 140/90 mm Hg or by being on hypertensive medication b Neither recognition nor initiation of hypertension treatment implies that the patient is adequately controlled (i.e., below 140/90 mm Hg).</s><s>The number of people without adequately controlled hypertension among those recognized/treated varies from country to country and usually exceeds the number of people with adequate control</s></p></note></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_1"><head>Table 2</head><label>2</label><figDesc><div><p><s>Blood pressure indicators among people with hypertension before and after the interventions among people with hypertension, 40-64 years old</s></p></div></figDesc><table><row><cell></cell><cell>Sex</cell><cell>Mean systolic BP a before</cell><cell>after</cell><cell>Δ b</cell><cell>% ≥ 140/90 mm Hg a before</cell><cell>after</cell><cell>Δ c</cell><cell>General population d</cell></row><row><cell>France</cell><cell>W</cell><cell>140.7</cell><cell>138.1</cell><cell>2.5</cell><cell>48%</cell><cell>41%</cell><cell>7%</cell><cell>2.0%</cell></row><row><cell></cell><cell>M</cell><cell>146.3</cell><cell>141.0</cell><cell>5.3</cell><cell>59%</cell><cell>48%</cell><cell>11%</cell><cell>5.3%</cell></row><row><cell>Germany</cell><cell>W</cell><cell>141.5</cell><cell>138.5</cell><cell>3.0</cell><cell>49%</cell><cell>42%</cell><cell>7%</cell><cell>2.0%</cell></row><row><cell></cell><cell>M</cell><cell>143.9</cell><cell>139.8</cell><cell>4.2</cell><cell>55%</cell><cell>45%</cell><cell>9%</cell><cell>3.4%</cell></row><row><cell>Italy</cell><cell>W</cell><cell>144.7</cell><cell>142.1</cell><cell>2.6</cell><cell>56%</cell><cell>51%</cell><cell>6%</cell><cell>1.8%</cell></row><row><cell></cell><cell>M</cell><cell>144.2</cell><cell>139.7</cell><cell>4.4</cell><cell>55%</cell><cell>45%</cell><cell>10%</cell><cell>4.0%</cell></row><row><cell>Spain</cell><cell>W</cell><cell>146.0</cell><cell>144.6</cell><cell>1.4</cell><cell>60%</cell><cell>57%</cell><cell>3%</cell><cell>1.0%</cell></row><row><cell></cell><cell>M</cell><cell>146.8</cell><cell>144.9</cell><cell>1.9</cell><cell>62%</cell><cell>57%</cell><cell>4%</cell><cell>1.8%</cell></row><row><cell>UK</cell><cell>W</cell><cell>141.5</cell><cell>139.5</cell><cell>2.0</cell><cell>50%</cell><cell>45%</cell><cell>5%</cell><cell>1.1%</cell></row><row><cell></cell><cell>M</cell><cell>145.4</cell><cell>142.8</cell><cell>2.5</cell><cell>58%</cell><cell>52%</cell><cell>5%</cell><cell>1.5%</cell></row><row><cell cols="4">For definitions and sources, see Additional file 2: Appendix 2 [109]</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row></table><note><p><s>a Blood pressure (BP) in mm Hg among people with hypertension, defined by a BP ≥ 140/90 mm Hg or by being on hypertensive medication b Difference between before and after interventions in mm Hg c % difference between before and after interventions d % increase of people below the threshold of 140/90 mm Hg in the general population</s></p></note></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_2"><head>Table 3</head><label>3</label><figDesc><div><p><s>Lives saved and disability-adjusted life years avoided in major disease categories within 12 months attributable to the interventions among people with hypertension, 40-64 years old For definitions and sources, see Additional file 2: Appendix 2 IHD ischemic heart disease, DALYs disability-adjusted life years the screening of hypertension via regular measurement of BP (for example, for the UK see the Quality and Outcomes Framework indicator set by the National Health Service; for underlying evidence see reviews</s></p></div></figDesc><table><row><cell>Deaths</cell><cell></cell><cell cols="2">Cardiovascular disease</cell><cell></cell><cell cols="2">Gastrointestinal disease</cell><cell></cell></row><row><cell></cell><cell></cell><cell>Total</cell><cell>Attributable to IHD</cell><cell>Attributable to stroke</cell><cell>Total</cell><cell>Attributable to liver cirrhosis</cell><cell>Injury</cell></row><row><cell>France</cell><cell>W</cell><cell>111</cell><cell>25</cell><cell>47</cell><cell>12</cell><cell>11</cell><cell>3</cell></row><row><cell></cell><cell>M</cell><cell>1041</cell><cell>443</cell><cell>276</cell><cell>109</cell><cell>88</cell><cell>30</cell></row><row><cell>Germany</cell><cell>W</cell><cell>275</cell><cell>83</cell><cell>98</cell><cell>25</cell><cell>22</cell><cell>2</cell></row><row><cell></cell><cell>M</cell><cell>1261</cell><cell>633</cell><cell>246</cell><cell>113</cell><cell>100</cell><cell>18</cell></row><row><cell>Italy</cell><cell>W</cell><cell>158</cell><cell>42</cell><cell>57</cell><cell>10</cell><cell>9</cell><cell>1</cell></row><row><cell></cell><cell>M</cell><cell>805</cell><cell>389</cell><cell>180</cell><cell>98</cell><cell>82</cell><cell>15</cell></row><row><cell>Spain</cell><cell>W</cell><cell>50</cell><cell>16</cell><cell>22</cell><cell>4</cell><cell>3</cell><cell>1</cell></row><row><cell></cell><cell>M</cell><cell>301</cell><cell>164</cell><cell>76</cell><cell>48</cell><cell>38</cell><cell>8</cell></row><row><cell>UK</cell><cell>W</cell><cell>77</cell><cell>27</cell><cell>29</cell><cell>25</cell><cell>24</cell><cell>2</cell></row><row><cell></cell><cell>M</cell><cell>378</cell><cell>220</cell><cell>78</cell><cell>84</cell><cell>75</cell><cell>11</cell></row><row><cell>DALYs</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>France</cell><cell>W</cell><cell>10,590</cell><cell>2850</cell><cell>5189</cell><cell>456</cell><cell>417</cell><cell>418</cell></row><row><cell></cell><cell>M</cell><cell>56,844</cell><cell>23,237</cell><cell>19,335</cell><cell>4235</cell><cell>3710</cell><cell>2914</cell></row><row><cell>Germany</cell><cell>W</cell><cell>21,179</cell><cell>7042</cell><cell>8703</cell><cell>1007</cell><cell>943</cell><cell>599</cell></row><row><cell></cell><cell>M</cell><cell>64,840</cell><cell>31,245</cell><cell>16,983</cell><cell>4491</cell><cell>4022</cell><cell>2379</cell></row><row><cell>Italy</cell><cell>W</cell><cell>15,543</cell><cell>4948</cell><cell>5872</cell><cell>489</cell><cell>452</cell><cell>536</cell></row><row><cell></cell><cell>M</cell><cell>47,273</cell><cell>21,992</cell><cell>13,020</cell><cell>4305</cell><cell>3777</cell><cell>2491</cell></row><row><cell>Spain</cell><cell>W</cell><cell>4764</cell><cell>1483</cell><cell>2100</cell><cell>181</cell><cell>159</cell><cell>233</cell></row><row><cell></cell><cell>M</cell><cell>16,419</cell><cell>8086</cell><cell>5007</cell><cell>1934</cell><cell>1660</cell><cell>1198</cell></row><row><cell>UK</cell><cell>W</cell><cell>4860</cell><cell>1648</cell><cell>2117</cell><cell>1012</cell><cell>936</cell><cell>495</cell></row><row><cell></cell><cell>M</cell><cell>18,354</cell><cell>9581</cell><cell>5348</cell><cell>3394</cell><cell>3033</cell><cell>1632</cell></row></table></figure>
		</body>
		<back>

			<div type="acknowledgement">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Acknowledgements</head><p><s>It should be noted that the views reported in this paper do not necessarily represent the views of the authors' employing organizations.</s></p><p><s>National Observatory on Alcohol, National Centre on Addiction and Doping, Istituto Superiore di Sanità, Rome, Italy. <ref type="bibr" target="#b31">30</ref></s><s>Società Italiana di Alcologia (SIA), Italian Society of Alcohology, Bologna, Italy. <ref type="bibr" target="#b32">31</ref></s><s>Centre for Interdisciplinary Addiction Research, Hamburg University, Universitätsklinik Hamburg-Eppendorf, Hamburg, Germany. <ref type="bibr" target="#b33">32</ref></s><s>Hypertension and Vascular Risk Unit, Internal Medicine Department, Hospital Clinic of Barcelona, IDIBAPS, University of Barcelona, Barcelona, Spain. <ref type="bibr" target="#b34">33</ref></s><s>Research Institute on Addictions, Federal Medical Research Centre for Psychiatry and Narcology n.a.</s><s>V. Serbsky, Moscow, Russia. <ref type="bibr" target="#b35">34</ref></s><s>Department of Psychiatry, Medical University of Warsaw, Warsaw, Poland. <ref type="bibr" target="#b36">35</ref></s><s>Drugs Intervention Group, semFYC, Ibiza Primary Health Care Center, Madrid, Spain.</s></p></div>
			</div>

			<div type="annex">
<div xmlns="http://www.tei-c.org/ns/1.0"><p><s>During implementation, priority should be given to the integration of routine screening for alcohol (recommendation 2) and interventions for hazardous and harmful drinking (recommendation 2) and AUDs (recommendation 3) into the management of hypertension.</s><s>Improved training and better remuneration systems, specifically adapted to the different healthcare systems, are crucial <ref type="bibr" target="#b59">[57]</ref>.</s><s>Some of the current steps in this direction are promising, and we hope that the reasoning and recommendations of this consensus paper can provide further important momentum to move European healthcare systems in this direction.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Additional file</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Funding</head><p><s>The workshop entitled "Screening and intervention for harmful alcohol use as a tool to improve the management of hypertension in primary care", held on November 12, 2015, in Barcelona, Spain, was financially supported by Lundbeck (in providing travel allowances for some participants).</s><s>An agenda of the workshop can be found in Additional file 1: Appendix 1.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Availability of data and materials</head><p><s>Data sources used for modelling are referenced.</s><s>No primary data were used.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Authors' contributions</head><p><s>All authors, except for DD, GG, JM, JAAP, and KDS, participated at the "Screening and intervention for harmful alcohol use as a tool to improve the management of hypertension in primary care" conference in Barcelona.</s><s>The discussions during this conference were condensed and compiled by JR, which resulted in the first draft of the manuscript.</s><s>DD, GG, JM, JAAP, and KDS contributed critical content to this manuscript.</s><s>All authors contributed to and approved of the final version.</s></p><p><s>Ethics approval and consent to participate Not applicable.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Consent for publication Not applicable.</head><p><s>Competing interests JR reports grants, personal fees and serving as board member (Nalmefene up to 2014) for Lundbeck.</s><s>PA reports no competing interests.</s><s>JAAP reports grants and personal fees from Lundbeck.</s><s>IA reports no competing interests.</s><s>H-JA reports serving as board member for Pfizer, D&amp;A Pharma, Ethypharm, and Lundbeck, and receiving sponsorships, speaker honoraria and consultancy fees from Bioprojet, D&amp;A Pharma, Ethypharm, Lundbeck, Merck-Serono, Novartis, and Pfizer.</s><s>MB reports consulting fees received from Lundbeck (through consulting business Copentown) for organisational and process support in connection with the project.</s><s>Copentown, which is owned by MB, also has other pharmaceutical/healthcare clients.</s><s>NBB reports funding from Lundbeck for a research project on alcohol.</s><s>CB reports consulting fees from Lundbeck.</s><s>RB reports no competing interests.</s><s>MC reports no competing interests.</s><s>JC reports sponsorship from Lundbeck to attend scientific meetings.</s><s>DD received consultant fee form Lundbeck. GG reports no competing interests.</s></p><p><s>AG reports grants and personal fees from Lundbeck and D&amp;A Pharma, grants from TEVA, and personal fees from Abbivie.</s><s>LK reports funding from Lundbeck for a research project on alcohol.</s><s>RK received honoraria for consultancy, lectures and support for research from Bayer Pharma, Berlin-Chemie Menarini, Bristol-Myers Squibb, Daiichi Sankyo, Lundbeck, and Servier.</s><s>HL reports consultation fee from Lundbeck.</s><s>JM reports personal fees from Lundbeck.</s><s>LM reports no competing interests.</s><s>LO reports no competing interests.</s><s>MR reports no competing interests.</s><s>ES reports sponsorship to attend scientific meetings from Lundbeck.</s><s>BS reports no competing interests.</s><s>LS-G reports sponsorship from Lundbeck to attend one scientific meeting.</s><s>KDS reports no competing interests.</s><s>CS reports sponsorship to attend scientific meetings from Lundbeck.</s><s>KV reports no competing interests.</s><s>MW reports personal fees from AOP Orphan, Berlin Chemie, Janssen, Lundbeck, D&amp;A Pharma, Reckitt Benckiser.</s><s>JZ reports personal fees from Lundbeck, and consultancy fees and salaries from Menarini, Lilly and Gilead.</s></p></div>			</div>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<monogr>
		<title level="m" type="main">World Health Organization. Global Action Plan for the Prevention and Control of NCDs</title>
		<imprint>
			<date type="published" when="2013">2013-2020. 2013</date>
			<pubPlace>Geneva: WHO</pubPlace>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">Hypertension prevalence and blood pressure levels in 6 European countries, Canada, and the United States</title>
		<author>
			<persName><forename type="first">K</forename><surname>Wolf-Maier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">S</forename><surname>Cooper</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">R</forename><surname>Banegas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Giampaoli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">W</forename><surname>Hense</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Joffres</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">JAMA</title>
		<imprint>
			<biblScope unit="volume">289</biblScope>
			<biblScope unit="page" from="2363" to="2369" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b2">
	<monogr>
		<title level="m" type="main">World Health Organization. A global brief on hypertension</title>
		<imprint>
			<date type="published" when="2013">2013</date>
			<pubPlace>Geneva</pubPlace>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main">Contribution of six risk factors to achieving the &quot;25 × 25&quot; NCD mortality reduction target</title>
		<author>
			<persName><forename type="first">V</forename><surname>Kontis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">D</forename><surname>Mathers</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Rehm</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">A</forename><surname>Stevens</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">D</forename><surname>Shield</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Bonita</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Lancet</title>
		<imprint>
			<biblScope unit="volume">384</biblScope>
			<biblScope unit="page" from="427" to="437" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main">Regional contributions of six preventable risk factors to achieving the 25 × 25 non-communicable disease mortality reduction target: a modelling study</title>
		<author>
			<persName><forename type="first">V</forename><surname>Kontis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">D</forename><surname>Mathers</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Bonita</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">A</forename><surname>Stevens</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Rehm</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">D</forename><surname>Shield</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Lancet Glob Health</title>
		<imprint>
			<biblScope unit="volume">3</biblScope>
			<biblScope unit="page" from="e746" to="e757" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main">World Economic Forum &amp; World Health Organization. From burden to &quot;best buys&quot;: Reducing the economic impact of non-communicable diseases in low-and middle-income countries</title>
	</analytic>
	<monogr>
		<title level="j">Davos: World Economic Forum</title>
		<imprint>
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main">Reducing the global burden of hazardous alcohol use: a comparative cost-effectiveness analysis</title>
		<author>
			<persName><forename type="first">D</forename><surname>Chisholm</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Rehm</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Van Ommeren</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Monteiro</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Stud Alcohol</title>
		<imprint>
			<biblScope unit="volume">65</biblScope>
			<biblScope unit="page" from="782" to="793" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
	</analytic>
	<monogr>
		<title level="m">Discussion Paper: Prevention and Control of NCDs: Priorities for Investment. Moscow: First Global Ministerial Conference on Healthy Lifestyles and Noncommunicable Disease Control</title>
				<imprint>
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b8">
	<monogr>
		<title level="m" type="main">Health Plan of Catalonia</title>
		<author>
			<persName><surname>Department</surname></persName>
		</author>
		<author>
			<persName><surname>Health</surname></persName>
		</author>
		<ptr target="http://salutweb.gencat.cat/ca/el_departament/Pla_salut/pla-de-salut-2016-2020/linies-estrategiques/.Accessed22" />
		<imprint>
			<date type="published" when="2016-02">2016-2020. 2016. Feb 2017</date>
			<pubPlace>Barcelona</pubPlace>
		</imprint>
	</monogr>
	<note>Government of Catalonia</note>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main">Alcoholinduced hypertension: an important healthcare target in Belgium</title>
		<author>
			<persName><forename type="first">F</forename><surname>Collart</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>De Timary</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Dom</forename><forename type="middle">G</forename><surname>Dor</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">D</forename><surname>Duprez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Lengelé</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">P</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Acta Clin Belg</title>
		<imprint>
			<biblScope unit="volume">70</biblScope>
			<biblScope unit="page" from="389" to="395" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b10">
	<monogr>
		<title level="m" type="main">Alkoholinkäytön suitsiminen vähentää kohonneen verenpaineen haittoja</title>
		<author>
			<persName><forename type="first">M</forename><surname>Aalto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Jula</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Keinänen-Kiukaanniemi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Liira</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Räsänen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Rehm</surname></persName>
		</author>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b11">
	<monogr>
		<title level="m" type="main">mini-interventiot ja riippuvuuden hoito voisivat merkittävästi vähentää kohonnutta verenpainetta sairastavien määrää. [Tackling alcohol consumption reduces high blood pressure damage. Alcohol Screening, briefinterventions and addiction treatment could significantly reduce</title>
		<author>
			<persName><forename type="first">Alkoholiseulonta</forename></persName>
		</author>
		<imprint/>
	</monogr>
	<note>elevated blood pressure in patients</note>
</biblStruct>

<biblStruct xml:id="b12">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">Suomen</forename><surname>Lääkärilehti</surname></persName>
		</author>
		<imprint>
			<date type="published" when="2017">2017</date>
			<biblScope unit="volume">35</biblScope>
			<biblScope unit="page" from="2177" to="2179A" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main">Verbessertes Hypertonie-Management durch Alkohol-Screening und Folgeinterventionen in der Hausarztpraxis</title>
		<author>
			<persName><forename type="first">J</forename><surname>Rehm</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Gmel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Kiefer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Kreutz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Kugler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Müller-Walther</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Deu Med Wochenschr</title>
		<imprint>
			<biblScope unit="volume">139</biblScope>
			<biblScope unit="page" from="2457" to="2462" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main">Cribado precoz e intervención breve en el consumo perjudicial de alcohol para mejorar el tratamiento de la hipertensión arterial en atención primaria</title>
		<author>
			<persName><forename type="first">A</forename><surname>Gual</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Zarco</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">F</forename><surname>Colom</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Rehm</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Med Clin Barcelona</title>
		<imprint>
			<biblScope unit="volume">146</biblScope>
			<biblScope unit="page" from="81" to="85" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b15">
	<monogr>
		<title level="m" type="main">Under Pressure: Tackling two of the most most common preventable health harms in the UK; high blood pressure and excessive alcohol consumption. Lundbeck</title>
		<author>
			<persName><forename type="first">J</forename><surname>Ballard</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Brown</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>'agnone</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Grimm</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Gunson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Harris</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename></persName>
		</author>
		<ptr target="https://www.alcohollearningcentre.org.uk/_assets/Treat%2015%20Under%20Pressure.pdf.Accessed7" />
		<imprint>
			<date type="published" when="2015-10">2015. Oct 2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main">Guidelines for accurate and transparent health estimates reporting: the GATHER statement</title>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">A</forename><surname>Stevens</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Alkema</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">E</forename><surname>Black</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">T</forename><surname>Boerma</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">S</forename><surname>Collins</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Ezzati</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Lancet</title>
		<imprint>
			<biblScope unit="volume">388</biblScope>
			<biblScope unit="page" from="e19" to="23" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main">The role of alcohol in the management of hypertension in patients in European primary health care practices -a survey in the largest European Union countries</title>
		<author>
			<persName><forename type="first">J</forename><surname>Rehm</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Angel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Prieto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Beier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Duhot</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Rossi</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">BMC Fam Prac</title>
		<imprint>
			<biblScope unit="volume">17</biblScope>
			<biblScope unit="page">130</biblScope>
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b18">
	<monogr>
		<title level="m" type="main">What is GRADE?</title>
		<author>
			<persName><surname>The Grade Working</surname></persName>
		</author>
		<author>
			<persName><surname>Group</surname></persName>
		</author>
		<ptr target="http://www.gradeworkinggroup.org/" />
		<imprint>
			<date type="published" when="2016-10-07">2016. Accessed 7 Oct 2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b19">
	<monogr>
		<title level="m" type="main">Lifestyle Interventions to Reduce Cardiovascular Risk</title>
		<author>
			<persName><forename type="first">U</forename><forename type="middle">S</forename></persName>
		</author>
		<ptr target="https://www.nhlbi.nih.gov/health-pro/guidelines/in-develop/cardiovascular-risk-reduction/lifestyle" />
		<imprint>
			<date type="published" when="2013-02-17">2013. 17 Feb 2017</date>
		</imprint>
	</monogr>
	<note>Department of Health and Human Services</note>
</biblStruct>

<biblStruct xml:id="b20">
	<monogr>
		<title level="m" type="main">National Institute for Health and Clinical Excellence. The Guidelines Manual. London: National Clinical Guideline Centre</title>
		<imprint>
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main">Alcohol and hypertension: gender differences in dose-response relationships determined through systematic review and meta-analysis</title>
		<author>
			<persName><forename type="first">B</forename><surname>Taylor</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">M</forename><surname>Irving</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Baliunas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Roerecke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Patra</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Mohapatra</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Addiction</title>
		<imprint>
			<biblScope unit="volume">104</biblScope>
			<biblScope unit="page" from="1981" to="1990" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main">Alcohol consumption and the risk of hypertension in men and women: a systematic review and meta-analysis</title>
		<author>
			<persName><forename type="first">A</forename><surname>Briasoulis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Agarwal</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">H</forename><surname>Messerli</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Clin Hypertens</title>
		<imprint>
			<biblScope unit="volume">14</biblScope>
			<biblScope unit="page" from="792" to="798" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main">Alcohol and cardiovascular health: the dose makes the poison…or the remedy</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">H</forename><surname>O'keefe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">K</forename><surname>Bhatti</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Bajwa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">J</forename><surname>Dinicolantonio</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">J</forename><surname>Lavie</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Mayo Clin Proc</title>
		<imprint>
			<biblScope unit="volume">89</biblScope>
			<biblScope unit="page" from="382" to="393" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main">Alcohol is bad for blood pressure</title>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">B</forename><surname>Puddey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">J</forename><surname>Beilin</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Exp Pharmacol Physiol</title>
		<imprint>
			<biblScope unit="volume">33</biblScope>
			<biblScope unit="page" from="847" to="852" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main">Alcohol and hypertension</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">L</forename><surname>Klatsky</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Gunderson</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m">Advanced Therapy in Hypertension and Vascular Disease</title>
				<editor>
			<persName><forename type="first">E</forename><forename type="middle">R</forename><surname>Mohler</surname></persName>
		</editor>
		<editor>
			<persName><forename type="first">R</forename><forename type="middle">R</forename><surname>Townsend</surname></persName>
		</editor>
		<meeting><address><addrLine>Hamilton</addrLine></address></meeting>
		<imprint>
			<publisher>BC Decker Inc</publisher>
			<date type="published" when="2006">2006</date>
			<biblScope unit="page" from="108" to="117" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main">Alcohol consumption and the risk of hypertension in women and men</title>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">D</forename><surname>Sesso</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">R</forename><surname>Cook</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">E</forename><surname>Buring</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">E</forename><surname>Manson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Gaziano</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Hypertension</title>
		<imprint>
			<biblScope unit="volume">51</biblScope>
			<biblScope unit="page" from="1080" to="1087" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title level="a" type="main">Higher prevalence of systemic HTN among moderate alcohol drinkers: exploring the role of under-reporting</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">L</forename><surname>Klatsky</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Gundersen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Kipp</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Udaltsova</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">D</forename><surname>Friedman</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Stud Alcohol</title>
		<imprint>
			<biblScope unit="volume">67</biblScope>
			<biblScope unit="page" from="421" to="428" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b28">
	<analytic>
		<title level="a" type="main">Alcohol-induced hypertension</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">B</forename><surname>Saunders</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Paton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">G</forename><surname>Beevers</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Lancet</title>
		<imprint>
			<biblScope unit="volume">2</biblScope>
			<biblScope unit="page" from="653" to="656" />
			<date type="published" when="1981">1981</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b29">
	<analytic>
		<title level="a" type="main">General practitioners recognizing alcohol dependence: a large crosssectional study in six European countries</title>
		<author>
			<persName><forename type="first">J</forename><surname>Rehm</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Allamani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Elekes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Jakubczyk</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Landsmane</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Manthey</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Ann Fam Med</title>
		<imprint>
			<biblScope unit="volume">13</biblScope>
			<biblScope unit="page" from="28" to="32" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b30">
	<analytic>
		<title level="a" type="main">The relationship between different dimensions of alcohol use and the burden of disease -an update</title>
		<author>
			<persName><forename type="first">J</forename><surname>Rehm</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">G</forename><surname>Gmel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">E</forename><surname>Gmel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Osm</forename><surname>Hasan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Imtiaz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Popova</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Addiction</title>
		<imprint>
			<biblScope unit="volume">112</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="968" to="1001" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b31">
	<analytic>
		<title level="a" type="main">Alcohol: an important cause of hypertension</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">B</forename><surname>Saunders</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">BMJ</title>
		<imprint>
			<biblScope unit="volume">294</biblScope>
			<biblScope unit="page" from="1045" to="1046" />
			<date type="published" when="1987">1987</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b32">
	<analytic>
		<title level="a" type="main">The relation between different dimensions of alcohol consumption and burden of disease -An overview</title>
		<author>
			<persName><forename type="first">J</forename><surname>Rehm</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Baliunas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">L</forename><surname>Borges</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Graham</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">M</forename><surname>Irving</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Kehoe</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Addiction</title>
		<imprint>
			<biblScope unit="volume">105</biblScope>
			<biblScope unit="page" from="817" to="843" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b33">
	<analytic>
		<title level="a" type="main">Effects of alcohol reduction on blood pressure: a meta-analysis of randomized controlled trials</title>
		<author>
			<persName><forename type="first">X</forename><surname>Xin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>He</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">G</forename><surname>Frontini</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">G</forename><surname>Ogden</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><forename type="middle">J</forename><surname>Motsamai</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">K</forename><surname>Whelton</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Hypertension</title>
		<imprint>
			<biblScope unit="volume">38</biblScope>
			<biblScope unit="page" from="1112" to="1117" />
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b34">
	<analytic>
		<title level="a" type="main">Blood pressure reduction during treatment for alcohol dependence: results from the Combining Medications and Behavioral Interventions for Alcoholism (COMBINE) study</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">H</forename><surname>Stewart</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">K</forename><surname>Latham</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">M</forename><surname>Miller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Randall</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">F</forename><surname>Anton</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Addiction</title>
		<imprint>
			<biblScope unit="volume">103</biblScope>
			<biblScope unit="page" from="1622" to="1628" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b35">
	<analytic>
		<title level="a" type="main">The effect of a reduction in alcohol consumption on blood pressure: a systematic review and meta-analysis of trial data</title>
		<author>
			<persName><forename type="first">M</forename><surname>Roerecke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Kaczorowski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">W</forename><surname>Tobe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Gmel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Osm</forename><surname>Hasan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Rehm</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Lancet Public Health</title>
		<imprint>
			<biblScope unit="volume">2</biblScope>
			<biblScope unit="page" from="e108" to="120" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b36">
	<monogr>
		<title level="m" type="main">Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0. The Cochrane Collaboration</title>
		<author>
			<persName><forename type="first">Jpt</forename><surname>Higgins</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Green</surname></persName>
		</author>
		<ptr target="http://handbook-5-1.cochrane.org/.Accessed15" />
		<imprint>
			<date type="published" when="2011-02">2011. Feb 2017</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b37">
	<analytic>
		<title level="a" type="main">Magnitude of blood pressure reduction in the placebo arms of modern hypertension trials: implications for trials of renal denervation</title>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">C</forename><surname>Patel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Hayward</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">A</forename><surname>Ozdemir</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">D</forename><surname>Rosen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Krum</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">R</forename><surname>Lyon</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Hypertension</title>
		<imprint>
			<biblScope unit="volume">65</biblScope>
			<biblScope unit="page" from="401" to="406" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b38">
	<analytic>
		<title level="a" type="main">2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of</title>
		<author>
			<persName><forename type="first">G</forename><surname>Mancia</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Fagard</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Narkiewicz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Redon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Zanchetti</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Bohm</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cardiology</title>
		<imprint>
			<publisher>ESC</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b39">
	<analytic>
		<title/>
	</analytic>
	<monogr>
		<title level="j">J Hypertens</title>
		<imprint>
			<biblScope unit="volume">31</biblScope>
			<biblScope unit="page" from="1281" to="1357" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b40">
	<analytic>
		<title level="a" type="main">Canadian Hypertension Society, Canadian Coalition for High Blood Pressure Prevention and Control, Laboratory Centre for Disease Control at Health Canada, Heart and Stroke Foundation of Canada</title>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">R</forename><surname>Campbell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Ashley</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">G</forename><surname>Carruthers</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Lacourcière</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">W</forename><surname>Mckay</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Can Med Assoc J</title>
		<imprint>
			<biblScope unit="volume">160</biblScope>
			<biblScope unit="page" from="S13" to="20" />
			<date type="published" when="1999">1999</date>
		</imprint>
	</monogr>
	<note>Lifestyle modifications to prevent and control hypertension. 3. Recommendations on alcohol consumption</note>
</biblStruct>

<biblStruct xml:id="b41">
	<monogr>
		<title level="m" type="main">Hypertension: The Clinical Management of Primary Hypertension in Adults: Update of Clinical Guidelines 18 and 34. London: Royal College of Physicians (UK) -National Clinical Guideline Centre</title>
		<imprint>
			<date type="published" when="2011">2011</date>
		</imprint>
		<respStmt>
			<orgName>National Clinical Guideline Centre</orgName>
		</respStmt>
	</monogr>
</biblStruct>

<biblStruct xml:id="b42">
	<analytic>
		<title level="a" type="main">Clinical practice guidelines for the management of hypertension in the community a statement by the American Society of Hypertension and the International Society of Hypertension</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Weber</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">L</forename><surname>Schiffrin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">B</forename><surname>White</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Mann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">H</forename><surname>Lindholm</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">G</forename><surname>Kenerson</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Hypertens</title>
		<imprint>
			<biblScope unit="volume">32</biblScope>
			<biblScope unit="page" from="3" to="15" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b43">
	<analytic>
		<title level="a" type="main">2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8)</title>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">A</forename><surname>James</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Oparil</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">L</forename><surname>Carter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">C</forename><surname>Cushman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Dennison-Himmelfarb</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Handler</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">JAMA</title>
		<imprint>
			<biblScope unit="volume">311</biblScope>
			<biblScope unit="page" from="507" to="520" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b44">
	<analytic>
		<title level="a" type="main">AHA/ACC guideline on lifestyle management to reduce cardiovascular risk: a report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">H</forename><surname>Eckel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Jakicic</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">D</forename><surname>Ard</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>De Jesus</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Houston</forename><surname>Miller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Hubbard</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">S</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Am Coll Cardiol</title>
		<imprint>
			<biblScope unit="volume">63</biblScope>
			<biblScope unit="page" from="2960" to="2984" />
			<date type="published" when="2013">2013. 2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b45">
	<analytic>
		<title level="a" type="main">Defining substance use disorders: do we really need more than heavy use?</title>
		<author>
			<persName><forename type="first">J</forename><surname>Rehm</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Marmet</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Anderson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Gual</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Kraus</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">J</forename><surname>Nutt</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Alcohol Alcohol</title>
		<imprint>
			<biblScope unit="volume">48</biblScope>
			<biblScope unit="page" from="633" to="640" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b46">
	<analytic>
		<title level="a" type="main">Quantifying the risk for alcohol-use and alcohol-attributable health disorders: present findings and future research needs</title>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">K</forename><surname>Li</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Gastroenterol Hepatol</title>
		<imprint>
			<biblScope unit="volume">23</biblScope>
			<biblScope unit="page" from="S2" to="8" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b47">
	<analytic>
		<title level="a" type="main">Sequelae of systemic hypertension in alcohol abstainers, light drinkers, and heavy drinkers</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">L</forename><surname>Klatsky</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Koplik</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Gunderson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Kipp</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">D</forename><surname>Friedman</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Cardiol</title>
		<imprint>
			<biblScope unit="volume">98</biblScope>
			<biblScope unit="page" from="1063" to="1068" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b48">
	<analytic>
		<title level="a" type="main">Excessive alcohol consumption and hypertension: clinical implications of current research</title>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">M</forename><surname>Miller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">F</forename><surname>Anton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">M</forename><surname>Egan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Basile</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">A</forename><surname>Nguyen</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Clin Hypertens</title>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="page" from="346" to="353" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b49">
	<analytic>
		<title level="a" type="main">Alcohol use disorders in Europe: a comparison of general population and primary health care prevalence rates</title>
		<author>
			<persName><forename type="first">J</forename><surname>Manthey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Gual</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Jakubczyk</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Pieper</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Probst</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Struzzo</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Subst Use</title>
		<imprint>
			<biblScope unit="volume">21</biblScope>
			<biblScope unit="page" from="478" to="484" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b50">
	<analytic>
		<title level="a" type="main">Alcohol dependence and treatment utilization in Europe -a representative cross-sectional study in primary care</title>
		<author>
			<persName><forename type="first">J</forename><surname>Rehm</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Allamani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Elekes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Jakubczyk</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Manthey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Probst</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">BMC Fam Prac</title>
		<imprint>
			<biblScope unit="volume">16</biblScope>
			<biblScope unit="page">90</biblScope>
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b51">
	<analytic>
		<title level="a" type="main">Who receives treatment for alcohol use disorders in the European Union? A cross-sectional representative study in primary and specialized health care</title>
		<author>
			<persName><forename type="first">J</forename><surname>Rehm</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Manthey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Struzzo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Gual</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Wojnar</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Euro Psych</title>
		<imprint>
			<biblScope unit="volume">30</biblScope>
			<biblScope unit="page" from="885" to="893" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b52">
	<analytic>
		<title level="a" type="main">Effectiveness of brief alcohol interventions in primary care populations</title>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">F</forename><surname>Kaner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Beyer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">O</forename><surname>Dickinson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Pienaar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Campbell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Schlesinger</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cochrane Database Syst Rev</title>
		<imprint>
			<biblScope unit="volume">18</biblScope>
			<biblScope unit="page">D004148</biblScope>
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b53">
	<analytic>
		<title level="a" type="main">Mesa Grande: a methodological analysis of clinical trials of treatments for alcohol use disorders</title>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">R</forename><surname>Miller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">L</forename><surname>Wilbourne</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Addiction</title>
		<imprint>
			<biblScope unit="volume">97</biblScope>
			<biblScope unit="page" from="265" to="277" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b54">
	<analytic>
		<title level="a" type="main">The effectiveness of psychosocial modalities in the treatment of alcohol problems in adults: a review of the evidence</title>
		<author>
			<persName><forename type="first">G</forename><surname>Martin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Rehm</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Can J Psychiatry</title>
		<imprint>
			<biblScope unit="volume">57</biblScope>
			<biblScope unit="page" from="350" to="358" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b55">
	<analytic>
		<title level="a" type="main">Van den Brink W. Extending the treatment options in alcohol dependence: a randomized controlled study of as-needed nalmefene</title>
		<author>
			<persName><forename type="first">K</forename><surname>Mann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Bladström</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Torup</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Gual</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biol Psychiat</title>
		<imprint>
			<biblScope unit="volume">73</biblScope>
			<biblScope unit="page" from="706" to="713" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b56">
	<analytic>
		<title level="a" type="main">ESENSE 2 Study Group. A randomised, double-blind, placebo-controlled, efficacy study of nalmefene, as-needed use, in patients with alcohol dependence</title>
		<author>
			<persName><forename type="first">A</forename><surname>Gual</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>He</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Torup</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Van Den Brink</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Mann</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Eur Neuropsychopharmacol</title>
		<imprint>
			<biblScope unit="volume">23</biblScope>
			<biblScope unit="page" from="1432" to="1442" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b57">
	<analytic>
		<title level="a" type="main">Long-term efficacy, tolerability and safety of nalmefene as-needed in patients with alcohol dependence: A 1-year, randomised controlled study</title>
		<author>
			<persName><forename type="first">W</forename><surname>Van Den Brink</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Sørensen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Torup</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Mann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Gual</surname></persName>
		</author>
		<author>
			<persName><surname>Sense Study</surname></persName>
		</author>
		<author>
			<persName><surname>Group</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Psychopharmacol</title>
		<imprint>
			<biblScope unit="volume">28</biblScope>
			<biblScope unit="page" from="733" to="744" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b58">
	<analytic>
		<title level="a" type="main">Alcohol screening and alcohol interventions among patients with hypertension in primary health care: An empirical survey of German general practitioners</title>
		<author>
			<persName><forename type="first">L</forename><surname>Kraus</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Schulte</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Manthey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Rehm</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Addict Res Theory</title>
		<imprint>
			<biblScope unit="volume">25</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="285" to="292" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b59">
	<analytic>
		<title level="a" type="main">Improving the delivery of brief interventions for heavy drinking in primary health care: outcome results of the Optimizing Delivery of Health Care Intervention (ODHIN) five-country cluster randomized factorial trial</title>
		<author>
			<persName><forename type="first">P</forename><surname>Anderson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Bendtsen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Spak</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Reynolds</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Drummond</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Segura</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Addiction</title>
		<imprint>
			<biblScope unit="volume">111</biblScope>
			<biblScope unit="page" from="1935" to="1945" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b60">
	<analytic>
		<title level="a" type="main">Barriers and facilitators to implementing screening and brief intervention for alcohol misuse: a systematic review of qualitative evidence</title>
		<author>
			<persName><forename type="first">M</forename><surname>Johnson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Jackson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Guillaume</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Meier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Goyder</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Public Health</title>
		<imprint>
			<biblScope unit="volume">33</biblScope>
			<biblScope unit="page" from="412" to="421" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b61">
	<analytic>
		<title level="a" type="main">Managing alcohol problems in general practice in Europe: results from the European ODHIN survey of general practitioners</title>
		<author>
			<persName><forename type="first">P</forename><surname>Anderson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Wojnar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Jakubczyk</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Gual</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Segura</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Sovinova</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Alcohol Alcohol</title>
		<imprint>
			<biblScope unit="volume">49</biblScope>
			<biblScope unit="page" from="531" to="539" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b62">
	<analytic>
		<title level="a" type="main">Guidelines on guidelines</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">D</forename><surname>Swales</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Hypertens</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="page" from="899" to="903" />
			<date type="published" when="1993">1993</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b63">
	<analytic>
		<title level="a" type="main">Joint National Committee on Detection Evaluation and Treatment of High Blood Pressure. The fifth report of the Joint National Committee on Detection, Evaluation and Treatment of High Blood Pressure (JNC V)</title>
	</analytic>
	<monogr>
		<title level="j">Arch Intern Med</title>
		<imprint>
			<biblScope unit="volume">153</biblScope>
			<biblScope unit="page" from="154" to="183" />
			<date type="published" when="1993">1993</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b64">
	<monogr>
		<title level="m" type="main">Comparative quantification of health risks. Global and regional burden of disease attributable to selected major risk factors</title>
		<author>
			<persName><forename type="first">M</forename><surname>Ezzati</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Lopez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Rodgers</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Cjl</forename><surname>Murray</surname></persName>
		</author>
		<imprint>
			<date type="published" when="2004">2004</date>
			<publisher>WHO</publisher>
			<pubPlace>Geneva</pubPlace>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b65">
	<analytic>
		<title level="a" type="main">A narrative review of alcohol consumption as a risk factor for global burden of disease</title>
		<author>
			<persName><forename type="first">J</forename><surname>Rehm</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Imtiaz</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Subst Abuse Treat Prev Policy</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="page">37</biblScope>
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b66">
	<analytic>
		<title level="a" type="main">The impact of brief alcohol interventions in primary healthcare: a systematic review of reviews</title>
		<author>
			<persName><forename type="first">A</forename><surname>O'donnell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Anderson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Newbury-Birch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Schulte</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Schmidt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Reimer</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Alcohol Alcohol</title>
		<imprint>
			<biblScope unit="volume">49</biblScope>
			<biblScope unit="page" from="66" to="78" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b67">
	<analytic>
		<title level="a" type="main">Alcohol drinking cessation and its effect on oesophageal and head and neck cancers: a pooled analysis</title>
		<author>
			<persName><forename type="first">J</forename><surname>Rehm</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Patra</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Popova</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Int J Cancer</title>
		<imprint>
			<biblScope unit="volume">121</biblScope>
			<biblScope unit="page" from="1132" to="1137" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b68">
	<analytic>
		<title level="a" type="main">The temporal relationship between per capita alcohol consumption and harm: a systematic review of time lag specifications in aggregate time series analyses</title>
		<author>
			<persName><forename type="first">J</forename><surname>Holmes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">S</forename><surname>Meier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Booth</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Guo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Brennan</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Drug Alcohol Depend</title>
		<imprint>
			<biblScope unit="volume">123</biblScope>
			<biblScope unit="page" from="7" to="14" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b69">
	<analytic>
		<title level="a" type="main">Liver cirrhosis mortality in Europe, with special attention to central and eastern Europe</title>
		<author>
			<persName><forename type="first">W</forename><surname>Zatonski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><surname>Sulkowska</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Manczuk</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Rehm</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">B</forename><surname>Lowenfels</surname></persName>
		</author>
		<author>
			<persName><forename type="first">La</forename><surname>Vecchia</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Eur Addict Res</title>
		<imprint>
			<biblScope unit="volume">16</biblScope>
			<biblScope unit="page" from="193" to="201" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b70">
	<analytic>
		<title level="a" type="main">Preventive Services Task Force Evidence Syntheses, formerly Systematic Evidence Reviews</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Piper</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">V</forename><surname>Evans</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">U</forename><surname>Burda</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">L</forename><surname>Margolis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O'</forename><surname>Connor</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Smith</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m">Screening for High Blood Pressure in Adults: A Systematic Evidence Review for the US Preventive Services Task Force. Rockville: Agency for Healthcare Research and Quality</title>
				<imprint>
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b71">
	<analytic>
		<title level="a" type="main">Preventive Services Task Force. Screening for high blood pressure: U.S. Preventive Services Task Force reaffirmation recommendation statement</title>
		<author>
			<persName><forename type="first">U</forename><forename type="middle">S</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Ann Intern Med</title>
		<imprint>
			<biblScope unit="volume">147</biblScope>
			<biblScope unit="page" from="783" to="786" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b72">
	<analytic>
		<title level="a" type="main">Screening for high blood pressure: a review of the evidence for the U.S. Preventive Services Task Force</title>
		<author>
			<persName><forename type="first">S</forename><surname>Sheridan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Pignone</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Donahue</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Prev Med</title>
		<imprint>
			<biblScope unit="volume">25</biblScope>
			<biblScope unit="page" from="151" to="158" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b73">
	<analytic>
		<title level="a" type="main">Improving cardiovascular health at population level: 39 community cluster randomised trial of Cardiovascular Health Awareness Program (CHAP)</title>
		<author>
			<persName><forename type="first">J</forename><surname>Kaczorowski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">W</forename><surname>Chambers</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Dolovich</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Paterson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Karwalajtys</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Gierman</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">BMJ</title>
		<imprint>
			<biblScope unit="volume">342</biblScope>
			<biblScope unit="page">442</biblScope>
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b74">
	<analytic>
		<title level="a" type="main">Relative effectiveness of clinic and home blood pressure monitoring compared with ambulatory blood pressure monitoring in diagnosis of hypertension: systematic review</title>
		<author>
			<persName><forename type="first">J</forename><surname>Hodgkinson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Mant</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><surname>Martin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Guo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">D</forename><surname>Hobbs</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">J</forename><surname>Deeks</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">BMJ</title>
		<imprint>
			<biblScope unit="volume">342</biblScope>
			<biblScope unit="page">3621</biblScope>
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b75">
	<monogr>
		<title level="m" type="main">Alcohol use disorders: diagnosis, assessment and management of harmful drinking and alcohol dependence</title>
		<imprint>
			<date type="published" when="2011">2011</date>
			<pubPlace>London: NICE</pubPlace>
		</imprint>
		<respStmt>
			<orgName>National Institute for Health and Clinical Excellence</orgName>
		</respStmt>
	</monogr>
</biblStruct>

<biblStruct xml:id="b76">
	<analytic>
		<title level="a" type="main">Assessment and management of alcohol use disorders</title>
		<author>
			<persName><forename type="first">E</forename><surname>Day</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Copello</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Hull</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">BMJ</title>
		<imprint>
			<biblScope unit="volume">350</biblScope>
			<biblScope unit="page">715</biblScope>
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b77">
	<analytic>
		<title level="a" type="main">Primary care management of alcohol use disorder and at-risk drinking: Part 2: counsel, prescribe, connect</title>
		<author>
			<persName><forename type="first">S</forename><surname>Spithoff</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Kahan</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Can Fam Physician</title>
		<imprint>
			<biblScope unit="volume">61</biblScope>
			<biblScope unit="page" from="515" to="521" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b78">
	<analytic>
		<title level="a" type="main">Alcohol use disorders in primary health care -what do we know and where do we go?</title>
		<author>
			<persName><forename type="first">J</forename><surname>Rehm</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Anderson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Manthey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">D</forename><surname>Shield</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Struzzo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Wojnar</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Alcohol Alcohol</title>
		<imprint>
			<biblScope unit="volume">51</biblScope>
			<biblScope unit="page" from="422" to="427" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b79">
	<analytic>
		<title level="a" type="main">Opioid antagonists for alcohol dependence</title>
		<author>
			<persName><forename type="first">S</forename><surname>Rösner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Hackl-Herrwerth</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Leucht</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Vecchi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Srisurapanont</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Soyka</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cochrane Database Syst Rev</title>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<biblScope unit="page">D001867</biblScope>
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b80">
	<analytic>
		<title level="a" type="main">Use of pharmacotherapies in the treatment of alcohol use disorders and opioid dependence in primary care</title>
		<author>
			<persName><forename type="first">J</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">F</forename><surname>Kresina</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Campopiano</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Lubran</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">W</forename><surname>Clark</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biomed Res Int</title>
		<imprint>
			<biblScope unit="page">137020</biblScope>
			<date type="published" when="2015">2015. 2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b81">
	<analytic>
		<title level="a" type="main">Alcohol consumption, %CDT, GGT and blood pressure change during alcohol treatment</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Baros</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">M</forename><surname>Wright</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">K</forename><surname>Latham</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">M</forename><surname>Miller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">F</forename><surname>Anton</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Alcohol Alcohol</title>
		<imprint>
			<biblScope unit="volume">43</biblScope>
			<biblScope unit="page" from="192" to="197" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b82">
	<analytic>
		<title level="a" type="main">Effect of alcohol abstinence on blood pressure</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">T</forename><surname>Aguilera</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>De La Sierra</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Coca</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Hypertension</title>
		<imprint>
			<biblScope unit="volume">33</biblScope>
			<biblScope unit="page" from="653" to="657" />
			<date type="published" when="1999">1999</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b83">
	<analytic>
		<title level="a" type="main">Randomised controlled trial of general practitioner intervention in patients with excessive alcohol consumption</title>
		<author>
			<persName><forename type="first">P</forename><surname>Wallace</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Cutler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Haines</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">BMJ</title>
		<imprint>
			<biblScope unit="volume">297</biblScope>
			<biblScope unit="page" from="663" to="668" />
			<date type="published" when="1988">1988</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b84">
	<analytic>
		<title level="a" type="main">The tangible common denominator of substance use disorders: a reply to commentaries to</title>
		<author>
			<persName><forename type="first">J</forename><surname>Rehm</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Anderson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Gual</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Kraus</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Marmet</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Room</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Alcohol Alcohol</title>
		<editor>Rehm et al.</editor>
		<imprint>
			<biblScope unit="volume">49</biblScope>
			<biblScope unit="page" from="118" to="122" />
			<date type="published" when="2013">2013. 2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b85">
	<analytic>
		<title level="a" type="main">Guideline on the Development of Medicinal Products for the Treatment of Alcohol Dependence</title>
		<author>
			<persName><forename type="first">Agency</forename><surname>European Medicines</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">European Medicines Agency</title>
		<imprint>
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b86">
	<analytic>
		<title level="a" type="main">Resistant hypertension-its identification and epidemiology</title>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">A</forename><surname>Sarafidis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Georgianos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">L</forename><surname>Bakris</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat Rev Nephrol</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="page" from="51" to="58" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b87">
	<analytic>
		<title level="a" type="main">Resistant hypertension: diagnosis, evaluation, and treatment: a scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">A</forename><surname>Calhoun</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Jones</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Textor</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">C</forename><surname>Goff</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">P</forename><surname>Murphy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">D</forename><surname>Toto</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Circulation</title>
		<imprint>
			<biblScope unit="volume">117</biblScope>
			<biblScope unit="page" from="e510" to="526" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b88">
	<analytic>
		<title level="a" type="main">Management of resistant hypertension. Expert consensus statement from the French Society of Hypertension, an affiliate of the French Society of Cardiology</title>
		<author>
			<persName><forename type="first">T</forename><surname>Denolle</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Chamontin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Doll</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">P</forename><surname>Fauvel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Girerd</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Herpin</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Presse Med</title>
		<imprint>
			<biblScope unit="volume">43</biblScope>
			<biblScope unit="page" from="1325" to="1331" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b89">
	<monogr>
		<title level="m" type="main">Tackling Harmful Alcohol Use: Economics and Public Health Policy</title>
		<imprint>
			<date type="published" when="2015">2015</date>
			<publisher>Organisation for Economic Co-operation and Development</publisher>
			<pubPlace>Paris</pubPlace>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b90">
	<analytic>
		<title level="a" type="main">What are the implications for policy makers? A systematic review of the cost-effectiveness of screening and brief interventions for alcohol misuse in primary care</title>
		<author>
			<persName><forename type="first">C</forename><surname>Angus</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Latimer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Preston</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Purshouse</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Front Psychiatry</title>
		<imprint>
			<biblScope unit="volume">5</biblScope>
			<biblScope unit="page">114</biblScope>
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b91">
	<analytic>
		<title level="a" type="main">Estimating the costeffectiveness of brief interventions for heavy drinking in primary health care across Europe</title>
		<author>
			<persName><forename type="first">C</forename><surname>Angus</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Thomas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Anderson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">S</forename><surname>Meier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Brennan</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Eur J Public Health</title>
		<imprint>
			<biblScope unit="volume">27</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="345" to="351" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b92">
	<monogr>
		<title level="m" type="main">ublic health successes and missed opportunities, Trends in alcohol consumption and attributable mortality in the WHO European Region</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">D</forename><surname>Shield</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Rylett</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Rehm</surname></persName>
		</author>
		<imprint>
			<date type="published" when="1990">1990-2014. 2016</date>
			<pubPlace>Copenhagen</pubPlace>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b93">
	<monogr>
		<title level="m" type="main">Methods for the Economic Evaluation of Health Care Programmes</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">F</forename><surname>Drummond</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Sculpher</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">W</forename><surname>Torrance</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">J</forename><surname>O'brien</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">L</forename><surname>Stoddart</surname></persName>
		</author>
		<imprint>
			<date type="published" when="2005">2005</date>
			<publisher>Oxford University Press</publisher>
			<pubPlace>New York</pubPlace>
		</imprint>
	</monogr>
	<note>3rd ed</note>
</biblStruct>

<biblStruct xml:id="b94">
	<analytic>
		<title level="a" type="main">Achievement of cardiometabolic goals in aware hypertensive patients in Spain: a nationwide population-based study</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">R</forename><surname>Banegas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Graciani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">J</forename><surname>De La Cruz-Troca</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">M</forename><surname>León-Muñoz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Guallar-Castillón</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Coca</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Hypertension</title>
		<imprint>
			<biblScope unit="volume">60</biblScope>
			<biblScope unit="page" from="898" to="905" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b95">
	<analytic>
		<title level="a" type="main">Niveau tensionnel moyen et prévalence de l&apos;hypertension artérielle chez les adultes de 18 à 74 ans</title>
		<author>
			<persName><forename type="first">H</forename><surname>Godet-Thobie</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Vernay</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Noukpoape</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Salanave</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Malon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Castebon</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">BEH Thématique</title>
		<imprint>
			<biblScope unit="page" from="478" to="483" />
			<date type="published" when="2006">2006-2007. 2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b96">
	<analytic>
		<title level="a" type="main">Blutdruck in Deutschland</title>
		<author>
			<persName><forename type="first">H</forename><surname>Neuhauser</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Thamm</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><surname>Ellert</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Ergebnisse der Studie zur Gesundheit Erwachsener in</title>
		<imprint>
			<biblScope unit="issue">DEGS1</biblScope>
			<date type="published" when="2008">2008-2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b97">
	<analytic>
		<title/>
	</analytic>
	<monogr>
		<title level="j">Bundesgesundheitsbl</title>
		<imprint>
			<biblScope unit="volume">56</biblScope>
			<biblScope unit="page" from="795" to="801" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b98">
	<analytic>
		<title level="a" type="main">The British Hypertension Society Protocol for the evaluation of blood pressure measuring devices</title>
		<author>
			<persName><forename type="first">E</forename><surname>O'brien</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Petrie</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">A</forename><surname>Littler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>De Swiet</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">L</forename><surname>Padfield</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Altman</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Hypertens</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="page" from="S43" to="63" />
			<date type="published" when="1993">1993</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b99">
	<monogr>
		<title level="m" type="main">Epidemiology and prevention of cerebrovascular and cardiovascular diseases</title>
		<author>
			<persName><surname>Cnesps -Instituto Superiore Di Sanita</surname></persName>
		</author>
		<ptr target="http://www.cuore.iss.it/fattori/pressione.asp.Accessed" />
		<imprint>
			<date type="published" when="2015-10-07">2015. 7 Oct 2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b100">
	<monogr>
		<title level="m" type="main">Health Search -Instituto di Ricerca Della SIMG. Firenze: Società Italiana di Medicina Generale e delle Cure Primarie</title>
		<author>
			<persName><forename type="first">E</forename><surname>Bianchini</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Brignoli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Cricelli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Cricelli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Giustini</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Medea</surname></persName>
		</author>
		<imprint>
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b101">
	<analytic>
		<title level="a" type="main">Prediction of coronary events in a low incidence population. Assessing accuracy of the CUORE Cohort Study prediction equation</title>
		<author>
			<persName><forename type="first">M</forename><surname>Ferrario</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Chiodini</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">E</forename><surname>Chambless</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Cesana</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Vanuzzo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Panico</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Int J Epidemiol</title>
		<imprint>
			<biblScope unit="volume">34</biblScope>
			<biblScope unit="page" from="413" to="421" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b102">
	<analytic>
		<title level="a" type="main">Treatment and blood pressure control in Spain during 2002-2010</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">L</forename><surname>Llisterri</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">C</forename><surname>Rodriguez-Roca</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Escobar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">J</forename><surname>Alonso-Moreno</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Prieto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Barrios</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Hypertens</title>
		<imprint>
			<biblScope unit="volume">30</biblScope>
			<biblScope unit="page" from="2425" to="2431" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b103">
	<analytic>
		<title level="a" type="main">Trends of uncontrolled blood pressure in Spain: an updated meta-regression analysis</title>
		<author>
			<persName><forename type="first">F</forename><surname>Catalá-López</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Ridao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Sanfélix-Gimeno</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Peiró</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Hypertens</title>
		<imprint>
			<biblScope unit="volume">31</biblScope>
			<biblScope unit="page" from="630" to="631" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b104">
	<analytic>
		<title level="a" type="main">Hypertension prevalence, awareness, treatment and control in national surveys from England, the USA and Canada, and correlation with stroke and ischaemic heart disease mortality: a cross-sectional study</title>
		<author>
			<persName><forename type="first">M</forename><surname>Joffres</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Falaschetti</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Gillespie</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Robitaille</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Loustalot</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Poulter</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">BMJ Open</title>
		<imprint>
			<biblScope unit="volume">3</biblScope>
			<biblScope unit="page">e003423</biblScope>
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b105">
	<monogr>
		<title level="m" type="main">Alcohol Dependence in Primary and Specialist Care in Europe -Data set</title>
		<author>
			<persName><forename type="first">J</forename><surname>Rehm</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Manthey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Gual</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Wojnar</surname></persName>
		</author>
		<idno type="DOI">10.6084/m9.figshare.2069585.v5</idno>
		<ptr target="https://dx.doi.org/10.6084/m9.figshare.2069585.v5" />
		<imprint>
			<date type="published" when="2016-10">October 2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b106">
	<analytic>
		<title level="a" type="main">The Blood Pressure &quot;Uncertainty Range&quot; -a pragmatic approach to overcome current diagnostic uncertainties (II)</title>
		<author>
			<persName><forename type="first">C</forename><surname>Pater</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Curr Control Trials Cardiovasc Med</title>
		<imprint>
			<biblScope unit="volume">6</biblScope>
			<biblScope unit="page">5</biblScope>
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b107">
	<monogr>
		<title level="m" type="main">Verenpainetasot ja hoitotasapaino FINRISKI-tutkimusaluiella</title>
		<author>
			<persName><forename type="first">T</forename><surname>Laatikainen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Jula</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Kastarinen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Salomaa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Borodulin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Harald</surname></persName>
		</author>
		<imprint>
			<date type="published" when="1982">1982-2012</date>
		</imprint>
	</monogr>
	<note>Blood pressure levels and therapeutic balance in FINRISK study areas in 1982-2012</note>
</biblStruct>

<biblStruct xml:id="b108">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">Suomen</forename><surname>Laakarilehti</surname></persName>
		</author>
		<imprint>
			<date type="published" when="2013">2013</date>
			<biblScope unit="volume">68</biblScope>
			<biblScope unit="page" from="1803" to="1809" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b109">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">S</forename><surname>Koskinen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Lundqvist</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Ristiluoma</surname></persName>
		</author>
		<author>
			<persName><surname>Terveys</surname></persName>
		</author>
		<author>
			<persName><surname>Suomessa</surname></persName>
		</author>
		<imprint>
			<date type="published" when="2011">2011. 2012</date>
		</imprint>
	</monogr>
	<note type="report_type">Tampere: Juvenes Print -Suomen Yliopistopaino Oy</note>
</biblStruct>

<biblStruct xml:id="b110">
	<monogr>
		<title level="m" type="main">World Health Organization. Global Health Estimates (GHE)</title>
		<ptr target="http://www.who.int/healthinfo/global_burden_disease/en/.Accessed" />
		<imprint>
			<date type="published" when="2016-07-19">2016. 19 July 2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b111">
	<analytic>
		<title level="a" type="main">Quantifying the burden of disease: the technical basis for disability-adjusted life years</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">J</forename><surname>Murray</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Bull World Health Organ</title>
		<imprint>
			<biblScope unit="volume">72</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="429" to="445" />
			<date type="published" when="1994">1994</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b112">
	<monogr>
		<title level="m" type="main">WHO methods and data sources for global burden of disease estimates</title>
		<ptr target="http://www.who.int/healthinfo/global_burden_disease/GlobalDALYmethods_2000_2015.pdf.Accessed7" />
		<imprint>
			<date type="published" when="2000">2000-2015. 2017. Aug 2017</date>
			<pubPlace>Geneva</pubPlace>
		</imprint>
		<respStmt>
			<orgName>WHO Department of Information, Evidence and Research</orgName>
		</respStmt>
	</monogr>
</biblStruct>

<biblStruct xml:id="b113">
	<analytic>
		<title level="a" type="main">Reduction of mortality following better detection of hypertension and alcohol problems in primary health care in Spain</title>
		<author>
			<persName><forename type="first">J</forename><surname>Rehm</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Gmel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Sierra</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Gual</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Adicciones</title>
		<imprint>
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
	<note>Ahead of print</note>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
